Illumina (ILMN) Net Equity Issued and Repurchased (2009 - 2026)
Illumina's (ILMN) quarterly Net Equity Issued and Repurchased came in at $24.0 million in Q1 2026, down 11.11% on a YoY basis from $27.0 million in Q1 2025, and up 50.0% quarter-over-quarter from $16.0 million in Q3 2025.
Analysis
Illumina (ILMN) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Illumina (ILMN) has reported Net Equity Issued and Repurchased for 18 consecutive years, with $24.0 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 11.11% year-over-year to $24.0 million; the trailing twelve-month figure through Jun 2026 stood at $40.0 million (down 16.67% YoY), and the FY2025 full-year result was $44.0 million, down 21.43% from the prior year.
- Net Equity Issued and Repurchased advanced to $24.0 million in Q1 2026 per ILMN's latest filing, from $16.0 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $37.0 million in Q2 2023 and bottomed at $1.0 million in Q2 2025.
- Historically, Net Equity Issued and Repurchased has averaged $22.8 million across 5 years, with a median of $25.5 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased gained 12.12% in 2023, then slumped 33.33% in 2024.
- Over 5 years, Net Equity Issued and Repurchased stood at $33.0 million in 2022, then fell by 9.09% to $30.0 million in 2023, then slumped by 33.33% to $20.0 million in 2024, then declined by 20.0% to $16.0 million in 2025, then soared by 50.0% to $24.0 million in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $24.0 million, $16.0 million, and $1.0 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 4.20 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 29, 2026 | 24.00 Mn |
| Sep 28, 2025 | 16.00 Mn |
| Jun 29, 2025 | 1.00 Mn |
| Mar 30, 2025 | 27.00 Mn |
| Sep 29, 2024 | 20.00 Mn |
| Mar 31, 2024 | 36.00 Mn |
| Oct 1, 2023 | 30.00 Mn |
| Apr 2, 2023 | 37.00 Mn |
| Jan 1, 2023 | 4.00 Mn |
| Apr 3, 2022 | 33.00 Mn |
| Oct 3, 2021 | 28.00 Mn |
| Apr 4, 2021 | 31.00 Mn |
| Sep 27, 2020 | 27.00 Mn |
| Jun 28, 2020 | 2.00 Mn |
| Mar 29, 2020 | 32.00 Mn |
| Sep 29, 2019 | 29.00 Mn |
| Jun 30, 2019 | 3.00 Mn |
| Mar 31, 2019 | 27.00 Mn |
| Dec 30, 2018 | 1.00 Mn |
| Sep 30, 2018 | 23.00 Mn |